Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

943 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prevention of left ventricular remodeling with granulocyte colony-stimulating factor after acute myocardial infarction: final 1-year results of the Front-Integrated Revascularization and Stem Cell Liberation in Evolving Acute Myocardial Infarction by Granulocyte Colony-Stimulating Factor (FIRSTLINE-AMI) Trial.
Ince H, Petzsch M, Kleine HD, Eckard H, Rehders T, Burska D, Kische S, Freund M, Nienaber CA. Ince H, et al. Among authors: freund m. Circulation. 2005 Aug 30;112(9 Suppl):I73-80. doi: 10.1161/CIRCULATIONAHA.104.524827. Circulation. 2005. PMID: 16159869 Clinical Trial.
Preservation from left ventricular remodeling by front-integrated revascularization and stem cell liberation in evolving acute myocardial infarction by use of granulocyte-colony-stimulating factor (FIRSTLINE-AMI).
Ince H, Petzsch M, Kleine HD, Schmidt H, Rehders T, Körber T, Schümichen C, Freund M, Nienaber CA. Ince H, et al. Among authors: freund m. Circulation. 2005 Nov 15;112(20):3097-106. doi: 10.1161/CIRCULATIONAHA.105.541433. Epub 2005 Nov 7. Circulation. 2005. PMID: 16275869 Clinical Trial.
Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies.
Stamm C, Kleine HD, Choi YH, Dunkelmann S, Lauffs JA, Lorenzen B, David A, Liebold A, Nienaber C, Zurakowski D, Freund M, Steinhoff G. Stamm C, et al. Among authors: freund m. J Thorac Cardiovasc Surg. 2007 Mar;133(3):717-25. doi: 10.1016/j.jtcvs.2006.08.077. Epub 2007 Feb 1. J Thorac Cardiovasc Surg. 2007. PMID: 17320570 Free article. Clinical Trial.
Granulocyte-colony stimulating factor response is superior to neutropenia duration in predicting the risk of infection after high-dose chemotherapy for myeloma and lymphoma.
Straka C, Salwender H, Schnabel B, Sandherr M, Wandt H, Hübel K, Scheid C, Metzner B, Hentrich M, Franke D, Weidenegger G, Freund M, Sezer O, Einsele H, Hinke A, Emmerich B. Straka C, et al. Among authors: freund m. Leuk Lymphoma. 2015 Feb;56(2):368-76. doi: 10.3109/10428194.2014.919631. Epub 2014 May 27. Leuk Lymphoma. 2015. PMID: 24794810
Allogeneic hematopoietic stem-cell transplantation in patients with hematologic malignancies after dose-escalated treosulfan/fludarabine conditioning.
Casper J, Wolff D, Knauf W, Blau IW, Ruutu T, Volin L, Wandt H, Schäfer-Eckart K, Holowiecki J, Giebel S, Aschan J, Zander AR, Kröger N, Hilgendorf I, Baumgart J, Mylius HA, Pichlmeier U, Freund M. Casper J, et al. Among authors: freund m. J Clin Oncol. 2010 Jul 10;28(20):3344-51. doi: 10.1200/JCO.2009.23.3429. Epub 2010 May 24. J Clin Oncol. 2010. PMID: 20498405
Chronic graft versus host disease but not the intensity of conditioning has impact on survival after allogeneic hematopoietic stem cell transplantation for advanced hematological diseases.
Hilgendorf I, Wolff D, Nogai A, Kundt G, Hahn J, Holler E, Uharek L, Junghanss C, Leithäuser M, Thiel E, Freund M, Kahl C. Hilgendorf I, et al. Among authors: freund m. Onkologie. 2012;35(9):487-92. doi: 10.1159/000341835. Epub 2012 Aug 13. Onkologie. 2012. PMID: 23007145 Clinical Trial.
Multimodal therapy for localized spinal epidural follicular lymphoma.
Kahl C, Hirt C, Decker S, Gläser D, Rohde S, Jost K, Hilgendorf I, Respondek-Dryba E, Leithäuser M, Junghanss C, Freund M. Kahl C, et al. Among authors: freund m. Onkologie. 2010;33(7):381-4. doi: 10.1159/000315769. Epub 2010 Jun 21. Onkologie. 2010. PMID: 20631485
Upfront denileukin diftitox as in vivo regulatory T-cell depletion in order to enhance vaccination effects in a canine allogeneic hematopoietic stem cell transplantation model.
Knueppel A, Lange S, Altmann S, Sekora A, Knuebel G, Vogel H, Lindner I, Freund M, Junghanss C. Knueppel A, et al. Among authors: freund m. Vet Immunol Immunopathol. 2012 Jan 15;145(1-2):233-40. doi: 10.1016/j.vetimm.2011.11.009. Epub 2011 Nov 25. Vet Immunol Immunopathol. 2012. PMID: 22173275
943 results